Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 739 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.2B 604 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| MM Major Medical DevicesCompany profile Develops innovative vascular intervention solutions for abdominal aortic aneurysms Develops innovative vascular intervention solutions for abdominal aortic aneurysms | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| B BradoCompany profile Provides Conversational Engagement Platform for patient navigation and engagement Provides Conversational Engagement Platform for patient navigation and engagement | Undisclosed | Undisclosed | Healthtech | United States | Investors | |
| F FineHeartCompany profile Develops cardiology devices, including the fully implantable FlowMaker system. Develops cardiology devices, including the fully implantable FlowMaker system. | €83M | Series CSeries C+ | Healthtech | France | Investors | |
| T TucuviCompany profile Tucuvi provides conversational AI for clinical patient follow-up and monitoring. Tucuvi provides conversational AI for clinical patient follow-up and monitoring. | $20M | Series A | Healthtech, AI | Spain | Investors | |
| V Develops and manufactures insulin patch pump systems for diabetes management | $13M | Series DSeries C+ | Healthtech | Netherlands | Investors | |
| V Builds technologies for spatial biology and multi-omics innovation | $48M | Series A | Healthtech, Biotech | United States | Investors | |
| F Medical imaging data management and analysis platform | $27.5M | Undisclosed | Healthtech | United States | Investors | |
| B BrightHeartCompany profile BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. | €11M | Series A | Healthtech, AI | France | Investors | |
| NT Nocion TherapeuticsCompany profile Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. Nocion Therapeutics develops small-molecule therapies for conditions involving cough and itch. | $23M | Series B+Series B | Healthtech, Biotech | United States | Investors Undisclosed | |
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $50M | Series A | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.